president Francisco Sagasti Announcing the signing of an agreement with Chinese pharmaceutical company Sinopharm for the supply of 38 million doses. Vaccine Against COVID-19 In a message to the nation, the president announced that the first million vaccines will arrive in January. Two times required
Read Also
- Gentil Duarte, head of the Farc dissidents, died in a confrontation with the ELN in Venezuela May 25, 2022
- A woman insists that the snow falling in Spain is “plastic” and has reacted on social networks (VIDEO) | MISCELLANY Jan 11, 2021
- The festival of literature for the little ones May 25, 2022
- María la del Barrio: The Story Behind Itatí Cantoral Return As Soraya Montegro After Her Death | Telenovelas | TV Series nnda nnlt | Fame Jan 12, 2021
- WEC: Cadillac-Dallara to start with LMDh in 2023 | FormulaPassion.it Aug 24, 2021
- At 81, he lives in a (tiny) cabin nestled in the heart of the Brocéliande forest. Nov 21, 2022
- Nastya Kamensky showed where she gets her curly May 10, 2020
This is the first agreement the Peruvian state has signed with a pharmaceutical company for the purchase of the vaccine.
Sinopharm vaccine is 79% effective and is “Conditional” for marketing from the Chinese health agency, Sinopharm is the first Chinese pharmaceutical group to report data on the effectiveness of vaccines in their preparations.
United Arab Emirates and Egypt It is the other two countries that have announced they have approved a vaccine made by Sinopharm with the Beijing Institute of Biological Products.
The efficacy rate of Sinopharm’s vaccine is lower than what competitors Pfizer / BioNTech (95%) and Moderna claim (94.1%).
Peru is part of the Phase III clinical trial of the Sinopharm vaccine. Thousands of people volunteer and receive both of these vaccines under the supervision of the Sinopharm. Cayetano Heredia Peruvian University (UPCH) and National University of San Marcos (UNMSM)
